2026 NPPES data Psychiatry Physician NPI 1558428037 MD
Verify on CMS →

BETH HAPKE, MD

Psychiatry Physician in BINGHAMTON, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
507
Medicare Part D claims · 39 beneficiaries · Psychiatry Physician avg: 1K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$28.64
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BETH HAPKE, MD filed 507 Medicare Part D claims in 2023 as a Psychiatry Physician in BINGHAMTON, New York, prescribing 92% generic.

507
Part D claims, 2023
92%
generic prescribing
$28.64
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BETH HAPKE, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

507 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

BETH HAPKE, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BETH HAPKE, MD?

Quality data not reported

NPI registry status

Active

Issued 01/03/2007

NPI 1558428037

Primary specialty

Psychiatry Physician

High-volume

53,104 US NPIs in this specialty

Medicare Part D claims

507 51% vs specialty avg

2023 prescription claims

Specialty avg: 1,038

Specialty distribution in New York

How Psychiatry Physician compares to other specialties among New York providers

New York providers

Psychiatry Physician share within New York

1. Psychiatry Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Psychiatry Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Psychiatry Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Psychiatry Physician ABMS/AOA estimate

Est. board-certified rate (Psychiatry Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Psychiatry Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BETH HAPKE, MD appears in the CMS NPPES registry as a Psychiatry Physician provider holding MD credentials at 425 ROBINSON STREET, BINGHAMTON, NY, 13904, with a listed phone of (607) 797-0680. NPI 1558428037 was issued on 01/03/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAPKE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 507 prescription claims written by this provider, covering 39 Medicare beneficiaries and totaling roughly $98K in drug spend, split 8% brand-name and 92% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Psychiatry Physician is a high-volume specialty nationwide, with 53,104 enrolled providers across 56 states and an average of 1,038 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

425 ROBINSON STREET
BINGHAMTON, NY 13904

Provider Details

NPI 1558428037
Specialty Psychiatry Physician
Credentials MD
Gender Female
NPI Issued 01/03/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BETH HAPKE, MD. Source: openpaymentsdata.cms.gov.

Total received

$29

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to BETH HAPKE, MD. To verify BETH HAPKE, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

BETH HAPKE, MD — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 507 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

507
Total Claims
$98K
Total Drug Cost
39
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
537
Total Day Supply
14,094
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$85K
Generic Drug Cost
$13K

Patient Demographics

Average Patient Age
57.9 years
Avg HCC Risk Score
1.51
Gender Split
51% female / 49% male
Age Distribution
<65: 26, 65-74: N/A, 75-84: N/A, 85+: 0

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BETH HAPKE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Clozapine
75
Prazosin Hcl
49
Fluoxetine Hcl
34
Olanzapine
32
Risperidone
31
Venlafaxine Hcl Er
Venlafaxine Hcl
27
Benztropine Mesylate
14
Divalproex Sodium
14
Mirtazapine
14
Vraylar
Cariprazine Hcl
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychiatry Physician Overview

How BETH HAPKE, MD fits within the Psychiatry Physician landscape nationally.

53,104
Psychiatry Physician Providers in US
56
States with Psychiatry Physician
1,038
Avg Claims per Provider

BETH HAPKE, MD's 507 claims are below the specialty average of 1,038.

Nearby Psychiatry Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as HAPKE.

Compare Psychiatry Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BETH HAPKE, MD's specialty?
BETH HAPKE, MD specializes in Psychiatry Physician and practices in BINGHAMTON, New York. Credentials: MD.
How much does BETH HAPKE, MD prescribe under Medicare Part D?
In 2023, BETH HAPKE, MD wrote 507 Medicare Part D claims totaling $98K in drug costs for 39 beneficiaries.
Where is BETH HAPKE, MD located?
BETH HAPKE, MD is located at 425 ROBINSON STREET, BINGHAMTON, NY, 13904. Phone: (607) 797-0680.
What is BETH HAPKE, MD's NPI number?
BETH HAPKE, MD's National Provider Identifier (NPI) is 1558428037, issued on 01/03/2007.
Does BETH HAPKE, MD prescribe more brand-name or generic drugs?
BETH HAPKE, MD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $85K in brand drug costs.
How many Psychiatry Physician providers are there in the US?
There are 53,104 Psychiatry Physician providers across 56 states in the US. The average Psychiatry Physician provider writes 1,038 Medicare Part D claims per year.
What drugs does BETH HAPKE, MD prescribe most often?
Based on 2023 Medicare Part D data, BETH HAPKE, MD's most frequently prescribed drugs include Clozapine, Prazosin Hcl, Fluoxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BETH HAPKE, MD accept Medicare?
BETH HAPKE, MD appears in CMS Medicare data with 507 Part D claims and 39 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BETH HAPKE, MD's credentials?
BETH HAPKE, MD's NPI is 1558428037 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology